Management of Multiple Tubular Adenomas in a 23-Year-Old Woman
This patient requires immediate referral to a specialist familial colorectal cancer clinic with access to genetic testing, followed by 1-2 yearly colonoscopic surveillance once genetic evaluation is complete. 1, 2
Immediate Action: Genetic Evaluation
The presence of multiple tubular adenomas in a young patient (age 23) mandates genetic evaluation regardless of family history. Approximately one-third of adenomatous polyposis patients have no family history 3, and these patients are typically diagnosed later (mean age 41 vs 32 years) and more often present symptomatically 3.
Specific Genetic Testing Required:
- APC gene testing (for FAP/attenuated FAP)
- MUTYH gene testing (for MAP - biallelic mutations)
- Consider multigene panel including AXIN2, GREM1, NTHL1, POLE, POLD1, MSH3 2
The absence of family history does NOT exclude hereditary polyposis syndromes. In fact, germline APC mutations are detected less frequently in patients without family history (24% vs 63%, p=0.007) 3, suggesting either de novo mutations or recessive inheritance patterns like MAP.
Surveillance Protocol Based on Polyp Count
The guidelines provide clear thresholds 1, 2:
If ≥10 adenomas detected:
- Colonoscopy every 1-2 years starting immediately
- This falls under "Multiple Colorectal Adenomas (MCRAs)" category 1
- Continue surveillance until age 75 years
If <10 adenomas but multiple present:
- Follow post-polypectomy guidelines
- Interval depends on adenoma characteristics (size, dysplasia, number)
Critical Pitfalls to Avoid
Do not wait for genetic test results to initiate surveillance. The young age (23 years) combined with multiple adenomas represents high-risk pathology requiring immediate action. Genetic testing guides long-term management but should not delay colonoscopic surveillance 1.
Do not assume negative family history excludes hereditary syndrome. These patients present later and are often symptomatic, suggesting delayed diagnosis rather than absence of genetic predisposition 3.
Additional Surveillance if Genetic Syndrome Confirmed
If FAP/Attenuated FAP (APC mutation):
- Colonoscopy every 1-3 years depending on phenotype 1
- Upper endoscopy starting at age 25 for duodenal surveillance 1
- Thyroid ultrasound screening
- Consider desmoid tumor surveillance (abdominal imaging)
If MAP (biallelic MUTYH mutations):
If No Mutation Identified:
- Continue 1-2 yearly colonoscopy surveillance 1
- Remains high-risk due to phenotype
- Consider that current genetic testing may not identify all causative variants
Why Specialist Referral is Mandatory
The BSG/ACPGBI/UKCGG guidelines strongly recommend referral to specialist services with access to constitutional genetic testing for patients with polyposis 1. This ensures:
- Comprehensive genetic counseling
- Appropriate multigene testing
- Coordinated surveillance protocols
- Family cascade testing if mutation identified
- Access to clinical trials and chemoprevention strategies
The NCCN guidelines similarly emphasize that genetic counseling by professionals with expertise in cancer genetics is essential when assessment identifies increased risk factors 2.
Long-term Management Considerations
At age 23, this patient faces decades of surveillance and potential interventions. The specialist team will need to monitor for:
- Progression of adenoma burden (may require prophylactic colectomy if burden increases)
- Development of advanced adenomas or early cancer
- Extracolonic manifestations if genetic syndrome confirmed
- Psychosocial support needs given young age at diagnosis
The key message: Act now with surveillance, refer to specialists for genetic evaluation, and do not be falsely reassured by negative family history. 1, 2, 3